Entera Bio Ltd. (ENTX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $42.0K | -75.6% |
| 2024 | $172.0K | — |
| 2023 | $0 | -100.0% |
| 2022 | $101.0K | -72.9% |
| 2021 | $373.0K | +24.3% |
| 2020 | $300.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $42.0K | -75.6% |
| 2024 | $172.0K | — |
| 2023 | $0 | -100.0% |
| 2022 | $101.0K | -72.9% |
| 2021 | $373.0K | +24.3% |
| 2020 | $300.0K | — |